188 related articles for article (PubMed ID: 32442855)
21. 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Sommerauer M; Burkhardt JK; Frontzek K; Rushing E; Buck A; Krayenbuehl N; Weller M; Schaefer N; Kuhn FP
Neuro Oncol; 2016 Jul; 18(7):1021-7. PubMed ID: 26865086
[TBL] [Abstract][Full Text] [Related]
22. Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma.
Müther M; Roll W; Brokinkel B; Zinnhardt B; Sporns PB; Seifert R; Schäfers M; Weckesser M; Stegger L; Stummer W; Rahbar K
Nuklearmedizin; 2020 Sep; 59(5):348-355. PubMed ID: 32691404
[TBL] [Abstract][Full Text] [Related]
23. Comparison of tc-99m depreotide and in-111 octreotide in recurrent meningioma.
Hellwig D; Samnick S; Reif J; Romeike BF; Reith W; Moringlane JR; Kirsch CM
Clin Nucl Med; 2002 Nov; 27(11):781-4. PubMed ID: 12394124
[TBL] [Abstract][Full Text] [Related]
24. Lung Metastases of Intracranial Atypical Meningioma Diagnosed on Posttherapeutic Imaging After 177Lu-DOTATATE Therapy.
Backhaus P; Huss S; Kösek V; Weckesser M; Rahbar K
Clin Nucl Med; 2018 Jun; 43(6):e184-e185. PubMed ID: 29688946
[TBL] [Abstract][Full Text] [Related]
25. Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [
Kim SH; Roytman M; Madera G; Magge RS; Liechty B; Ramakrishna R; Pannullo SC; Schwartz TH; Karakatsanis NA; Osborne JR; Lin E; Knisely JPS; Ivanidze J
Sci Rep; 2022 Jun; 12(1):9256. PubMed ID: 35661809
[TBL] [Abstract][Full Text] [Related]
26. High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
Hildebrandt G; Scheidhauer K; Luyken C; Schicha H; Klug N; Dahms P; Krisch B
Acta Neurochir (Wien); 1994; 126(2-4):63-71. PubMed ID: 8042557
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
Haldemann AR; Rösler H; Barth A; Waser B; Geiger L; Godoy N; Markwalder RV; Seiler RW; Sulzer M; Reubi JC
J Nucl Med; 1995 Mar; 36(3):403-10. PubMed ID: 7884502
[TBL] [Abstract][Full Text] [Related]
28. A Prospective Registry Study of
Perlow HK; Nalin AP; Handley D; Gokun Y; Blakaj DM; Beyer SJ; Thomas EM; Raval RR; Boulter D; Kleefisch C; Bovi J; Chen WC; Braunstein SE; Raleigh DR; Knisely JPS; Ivanidze J; Palmer JD
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):979-985. PubMed ID: 37871886
[TBL] [Abstract][Full Text] [Related]
29. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
30. Somatostatin receptor scintigraphy for optic nerve sheath meningiomas.
Saeed P; Tanck MW; Freling N; Baldeschi L; Mourits MP; Bennink RJ
Ophthalmology; 2009 Aug; 116(8):1581-6. PubMed ID: 19500849
[TBL] [Abstract][Full Text] [Related]
31. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
Wang F; Wang Z; Wu J; Qu W; Yao W; Zhao J; Liu Z
Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351
[TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine tumors in the brain.
Cavalla P; Schiffer D
Ann Oncol; 2001; 12 Suppl 2():S131-4. PubMed ID: 11762340
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin receptor scintigraphy in the differential diagnosis of meningioma.
Bohuslavizki KH; Brenner W; Braunsdorf WE; Behnke A; Tinnemeyer S; Hugo HH; Jahn N; Wolf H; Sippel C; Clausen M; Mehdorn HM; Henze E
Nucl Med Commun; 1996 Apr; 17(4):302-10. PubMed ID: 8786866
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptor imaging: current status and future perspectives.
Bohuslavizki KH
J Nucl Med; 2001 Jul; 42(7):1057-8. PubMed ID: 11438628
[No Abstract] [Full Text] [Related]
35. Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
Iglseder S; Iglseder A; Beliveau V; Heugenhauser J; Gizewski ER; Kerschbaumer J; Stockhammer G; Uprimny C; Virgolini I; Dudas J; Nevinny-Stickel M; Nowosielski M; Scherfler C
J Neurooncol; 2023 Sep; 164(3):711-720. PubMed ID: 37707754
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
37. Somatostatin receptors in meningiomas: a scintigraphic study using 111In-DTPA-D-Phe-1-octreotide.
Maini CL; Tofani A; Sciuto R; Carapella C; Cioffi R; Crecco M
Nucl Med Commun; 1993 Jul; 14(7):550-8. PubMed ID: 8355914
[TBL] [Abstract][Full Text] [Related]
38. Improved Detection of Transosseous Meningiomas Using
Kunz WG; Jungblut LM; Kazmierczak PM; Vettermann FJ; Bollenbacher A; Tonn JC; Schichor C; Rominger A; Albert NL; Bartenstein P; Reiser MF; Cyran CC
J Nucl Med; 2017 Oct; 58(10):1580-1587. PubMed ID: 28450556
[No Abstract] [Full Text] [Related]
39. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
40. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
